首页|Silpakorn University Reports Findings in Personalized Medicine (The Artificial I ntelligence-Powered New Era in Pharmaceutical Research and Development: A Review )
Silpakorn University Reports Findings in Personalized Medicine (The Artificial I ntelligence-Powered New Era in Pharmaceutical Research and Development: A Review )
扫码查看
点击上方二维码区域,可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Drugs and Therapies - Personalized Medicine is the subject ofa report. According to news reporting ou t of Nakorn Panom, Thailand, by NewsRx editors, researchstated, “Currently, art ificial intelligence (AI), machine learning (ML), and deep learning (DL) are gaining increased interest in many fields, particularly in pharmaceutical research and development, wherethey assist in decision-making in complex situations. Num erous research studies and advancements havedemonstrated how these computationa l technologies are used in various pharmaceutical research anddevelopment aspec ts, including drug discovery, personalized medicine, drug formulation, optimizat ion,predictions, drug interactions, pharmacokinetics/ pharmacodynamics, quality control/quality assurance,and manufacturing processes.”